血府逐瘀胶囊与西比灵联合治疗偏头痛60例临床观察

目的：观察血府逐瘀胶囊联合西比灵治疗偏头痛的临床疗效。方法：将120例偏头痛患者随机分为两组,对照组60例给予西比灵口服治疗;治疗组60例在此基础上加用血府逐瘀胶囊治疗;两组均连续治疗30 d。观察两组患者临床症状及体征,并对血液流变学指标和TCD检查结果进行对比分析。结果：对照组总有效率为78.3%,治疗组总有效率为93.3%,治疗组临床疗效明显优于对照组（P〈0.05）。结论：血府逐瘀胶囊治疗偏头痛具有显著疗效,其与西比灵联合使用临床疗效更好。

Clinical Observation of Xuefuzhuyu Capsule and Sibelius Capsule on 60 cases of Migraine

Objective： To observe the clinical efficacy of Xuefuzhuyu capsule Sibelius capsule on Migraine. Methods： The 120 patients with migraine were randomly divided into two groups; the 60 patients were given oral treatment Sibelius capsule in control group, and the 60 patients were treated Xuefuzhuyu capsule as well as Sibelius capsule in treatment group. Both groups were treated for 30 consecutive days. The clinical symptoms, signs, blood theology and TCD examination results were analyzed, Results： The total effective rate was 78.3% in control group, and 95.3% in treatment group, which was significantly better than the control group （P〈0.05）. Conclusion： Xuefuzhuyu capsules can provide significant effect for migraine, and the combination with Sibelius was able to achieve a more favorable clinical outcomes.